Thalidomide Attenuates Skin Lesions and Inflammation in Rosacea-Like Mice Induced by Long-Term Exposure of LL-37
Yumeng Kang,1 Chuanxi Zhang,1 Yang He,1 Ziyan Zhang,1 Heliang Liu,2 Zhongqiu Wei,3 Jie Yang1 1Department of Dermatology, Affiliated Hospital of North China University of Science and Technology, Tangshan, People's Republic of China; 2Hebei Key Laboratory for Organ Fibrosis Research, School of Pu...
Saved in:
Main Authors: | Kang Y (Author), Zhang C (Author), He Y (Author), Zhang Z (Author), Liu H (Author), Wei Z (Author), Yang J (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
In silico investigation of potential interleukin-8 (IL-8) and Cathelicidin (LL-37) inhibitors for rosacea treatment
by: Taufik Muhammad Fakih, et al.
Published: (2024) -
Renovation as innovation: Repurposing human antibacterial peptide LL-37 for cancer therapy
by: Fatai Lu, et al.
Published: (2022) -
Expression and significance of serum vitamin D and LL-37 levels in infants with bacterial pneumonia
by: Shaojie Zhao, et al.
Published: (2022) -
Antibacterial and Anti-Inflammatory Properties of a Novel Antimicrobial Peptide Derived from LL-37
by: Haiwei Zhuo, et al.
Published: (2022) -
Antimicrobial Peptide Loss, Except for LL-37, is not Characteristic of Atopic Dermatitis
by: Lilla Szabó, et al.
Published: (2023)